Pharma Company Gains Visibility into Clinical Trials through Standardization, Aggregation, and Analysis of Trial Repository

Sep 23, 2016

Business Challenge

Setting up data repository for analysis of clinical trials.

A leading client in the pharmaceutical companies space with a growing pipeline wanted to set up a data repository to analyze data across clinical trials.

Situation: Limited visibility into clinical trials

The client in the pharmaceutical companies space had legacy and on-going clinical trials data in different formats and systems. They had limited ability to visualize and analyze data across trials, and inability to aggregate and standardize data for analysis and submission.


Standardization of all clinical data using CDISC SDTM and CDASH standards.

To know more about the role of analytics in improving the efficiency of clinical trials, request a FREE proposal.

We worked with the client to determine their goals and requirements, and setup clinical data repository. We aggregated and standardized all of their clinical data using CDISC SDTM and CDASH standards and mapped their legacy data leveraging next generation ETL capabilities. We developed programs and derivations to convert, integrate, and standardize their data into the platform.


Better access to multi-dimensional data for decision-making.

The client in the pharmaceutical companies space was able to access and perform analysis and on multi-dimensional clinical data views by role (i.e., safety analysts, data managers, medical monitors, biostatisticians, and clinical trial managers). Our solution also helped the client implement data standards based on CDISC’s SDTM for all legacy, on-going, and future trial data to expedite data analysis and submission.

Recent Case Studies


Our advanced analytics expertise spans across industries, sectors, and functions, which enables us to deliver robust, agile solutions to all our clients. These are our core competencies, formed through years of experience.


Our free resources shed light on our extensive expertise and equip you with information to accelerate decision-making, growth, and innovation.

Talk to us
Talk to us